A study in which none of the participants nor examining doctors, know who is taking the test drug and who is taking control agent (also known as a simulated medication or placebo). The purpose of this research design is to avoid inadvertent bias of the test results.
Increasing awareness, participation, funding and streamlining communication for MS trials